Abdullah Mohammed Al Majid

Title: Abdullah Mohammed Al Majid: Innovator in Cancer Treatment

Introduction

Abdullah Mohammed Al Majid is a prominent inventor based in Riyadh, Saudi Arabia. He has made significant contributions to the field of cancer treatment through his innovative research and development of novel compounds. With a total of 3 patents, Al Majid is recognized for his dedication to advancing medical science.

Latest Patents

One of Al Majid's latest patents is focused on the nanoformulation of spirooxindole and methods for treating hepatocellular carcinoma. This innovative spirooxindole nanoformulation includes a proniosome loaded with a spirooxindole derivative. The spirooxindole derivative comprises a compound that acts as an MDM2-p53 inhibitor, featuring a complex fused ring system that is ideally suited for binding to the MDM2 protein. This binding interrupts the protein-protein interaction, which is crucial in cancer progression. Testing has shown that these compounds exhibit anti-cancer activity against various forms of cancer cells affecting humans.

Career Highlights

Throughout his career, Abdullah Mohammed Al Majid has worked at King Saud University, where he has contributed to various research projects and initiatives. His work has been instrumental in developing new therapeutic strategies for cancer treatment.

Collaborations

Al Majid has collaborated with notable colleagues, including Assem Barakat and Mohammad Shahidul Islam. These collaborations have further enhanced his research and innovation in the field of cancer treatment.

Conclusion

Abdullah Mohammed Al Majid is a dedicated inventor whose work in cancer treatment has the potential to make a significant impact on medical science. His innovative approaches and collaborations highlight his commitment to advancing healthcare solutions.